Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data.
Choi SI, Kim SK, Park S, Kim JH, Ihm SH, Kim GI, Kim WS, Pyun WB, Kim YM, Shin J. Choi SI, et al. Among authors: kim gi, kim ym, kim sk, kim ws, kim jh. Clin Hypertens. 2016 Jan 27;22:8. doi: 10.1186/s40885-016-0045-x. eCollection 2015. Clin Hypertens. 2016. PMID: 26893941 Free PMC article.
Not nondipping but nocturnal blood pressure predicts left ventricular hypertrophy in the essential hypertensive patients: the Korean Ambulatory Blood Pressure multicenter observational study.
Yi JE, Shin J, Ihm SH, Kim JH, Park S, Kim KI, Kim WS, Pyun WB, Kim YM, Kim SK. Yi JE, et al. Among authors: kim ym, kim sk, kim ws, kim jh, kim ki. J Hypertens. 2014 Oct;32(10):1999-2004; discussion 2004. doi: 10.1097/HJH.0000000000000272. J Hypertens. 2014. PMID: 25023153
Erratum to: Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data.
Choi SI, Kim SK, Park S, Kim JH, Ihm SH, Kim GI, Kim WS, Pyun WB, Kim YM, Shin J. Choi SI, et al. Among authors: kim gi, kim ym, kim sk, kim ws, kim jh. Clin Hypertens. 2016 Feb 29;22:14. doi: 10.1186/s40885-016-0048-7. eCollection 2016. Clin Hypertens. 2016. PMID: 26933509 Free PMC article.
Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
Cho EJ, Lee HY, Sung KC, Park S, Sohn IS, Park CG, Choi DJ, Ha JW, Ahn YK, Shin J, Hong SJ, Kim SK, Chung WJ, Yoo BS, Hong TJ, Youn HJ, Cho MC, Chae SC, Kim YJ, Kim CJ. Cho EJ, et al. Among authors: kim yj, kim cj, kim sk. Am J Hypertens. 2019 Sep 24;32(10):992-1002. doi: 10.1093/ajh/hpz050. Am J Hypertens. 2019. PMID: 31099387 Free PMC article. Clinical Trial.
The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazide.
Shin J, Lee HY, Chung WJ, Youn HJ, Cho EJ, Sung KC, Chae SC, Yoo BS, Park CG, Hong SJ, Hong TJ, Choi DJ, Ha JW, Kim YJ, Ahn YK, Cho MC, Kim SK, Park S, Sohn IS, Kim CJ. Shin J, et al. Among authors: kim yj, kim cj, kim sk. J Hypertens. 2019 Dec;37(12):2490-2497. doi: 10.1097/HJH.0000000000002202. J Hypertens. 2019. PMID: 31373922 Free PMC article. Clinical Trial.
Type 2 myocardial infarction following generalized tonic-clonic seizure.
Park J, Shin JH, Kim SH, Lim YH, Lee JU, Kim KS, Kim SK, Kim JH, Lim HK, Shin J. Park J, et al. Among authors: kim sh, kim ks, kim sk, kim jh. Korean Circ J. 2011 Nov;41(11):681-4. doi: 10.4070/kcj.2011.41.11.681. Epub 2011 Nov 29. Korean Circ J. 2011. PMID: 22194766 Free PMC article.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study.
Woo JS, Hong SJ, Cha DH, Kim KS, Kim MH, Lee JW, Jeong MH, Jeong JO, Lee JH, Jeon DS, Cho EJ, Kim SK, Kwan J, Park CG, Lee HY, Hong TJ, Shin J, Youn HJ, Jeon DW, Chung WJ, Jeong JC, Kim CJ. Woo JS, et al. Among authors: kim cj, kim ks, kim sk, kim mh. Clin Ther. 2021 Aug;43(8):1419-1430. doi: 10.1016/j.clinthera.2021.07.001. Epub 2021 Jul 29. Clin Ther. 2021. PMID: 34332788 Free article. Clinical Trial.
7,194 results